Replies to post #25908 on Biotech Values

[DewDiligence]

>So case in point, Colin Goddard's brutal impact on the OSI shareprice over the recent fiscal year would mean that he gets some options that are priced around 50 per share, rather than the ~30 dollar share price that the stock currently trades at.<

If I were on OSIP’s BoD, I would propose that Goddard’s options be repriced upward!